Loading clinical trials...
Loading clinical trials...
A Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions
Interventions
alvocidib
Locations
1
United States
Ohio State University Medical Center
Columbus, Ohio, United States
Start Date
April 1, 2003
Primary Completion Date
February 1, 2009
Completion Date
February 1, 2009
Last Updated
July 2, 2017
NCT04195633
NCT04169737
NCT06839053
NCT06859008
NCT05246345
NCT02427451
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions